SCHEDULE 13G/A
Statement of Beneficial Ownership
AgomAb Therapeutics NV Filed Acc 0000905148-26-004929
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Redmile Group, LLC | 1,740,230 | 3.5% |
| Jeremy C. Green | 1,740,230 | 3.5% |
| Redmile Biopharma Investments III, L.P. | 1,740,230 | 3.5% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Loading xslSCHEDULE_13G_X02/primary_doc.xml…